AMGN made an upfront payment of $400 million to Kyowa. Apart from eczema, the companies are also developing the drug for prurigo nodularis (phase III) and asthma (phase II).

Types of systemic medications that may be used to treat atopic eczema include: Oral corticosteroids. Prednisone and other drugs from this class of medications reduce inflammation. They’re ...

Novartis has axed development of its mid-stage eczema drug ZPL389, taking a $485 million hit in the process. Buried deep in the Swiss company’s Q2 results statement, the company said it had ...

New data shows Ebglyss achieved deep and sustained response for patients with moderate-to-severe atopic dermatitis (eczema ... Also Read: Alzheimer’s Drugs From Eli Lilly And Biogen Still ...

Like people, eczema comes in many colors. It can appear as red patches in lighter skin, and in gray, purple or dark brown patches in people with darker skin. Patches may also be thicker and/or ...

Eczema is a chronic disease that usually begins ... Experts hail highly successful trial of Lilly's cholesterol-busting drug lepodisiran April 2 (UPI) -- Heart disease experts are hailing the ...

EH most commonly affects infants and young children who have eczema or other inflammatory skin conditions. It can also affect adults. Antiviral drugs treat EH. It can become severe and life ...

While the IGNITE study evaluated rocatinlimab as monotherapy for 24 weeks, the SHUTTLE study evaluated the drug in combination with topical corticosteroids (TCS) and/or topical calcineurin ...